Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options.

by Pierluigi Gasparini, Matteo Fassan, Luciano Cascione, Gulnur Guler, Serdar Balci, Cigdem Irkkan, Carolyn Paisie, Francesca Lovat, Carl Morrison, Jianying Zhang, Aldo Scarpa, Carlo M Croce, Charles L Shapiro, Kay Huebner
Published 2014-01-01